During melanoma progression, there are various soluble factors released by tumor and immunosuppressive immune cells, which disrupt the proper function of dendritic cells in priming naïve T-cells into effector CD8+ T-cells in the lymph nodes (Figure 3) [256,304,306,307]. Here, CD8A is linked to melanoma.